Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Replacement in Postmenopausal Hypercalciuria
NCT01928082Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in hypercalciuria, osteopenia, osteoporosis, sponsored by University of Chicago. Started Aug 2013; status: terminated.
02
Drugs
estradiol
03
Conditions
hypercalciuriaosteopeniaosteoporosis
Beyond the preview
Go deeper on NCT01928082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928082.